Viewing Study NCT01431534


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-03-02 @ 4:11 AM
Study NCT ID: NCT01431534
Status: TERMINATED
Last Update Posted: 2019-03-01
First Post: 2011-09-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-01-30
Start Date Type: ACTUAL
Primary Completion Date: 2013-08-20
Primary Completion Date Type: ACTUAL
Completion Date: 2018-05-25
Completion Date Type: ACTUAL
First Submit Date: 2011-09-07
First Submit QC Date: None
Study First Post Date: 2011-09-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-10-29
Results First Submit QC Date: None
Results First Post Date: 2019-03-01
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-02-27
Last Update Post Date: 2019-03-01
Last Update Post Date Type: ACTUAL